Gliclazide-d4

• CAT Number: S000073
• CAS Number: 1185039-30-8
• Molecular Formula: C15H17D4N3O3S
• Molecular Weight: 327.44
• Purity: ≥95%
• Target: Potassium Channel
• IUPAC Name: 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(2,3,5,6-tetradeuterio-4-methylphenyl)sulfonylurea
• InChI: InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/i5D,6D,7D,8D
• InChIKey: BOVGTQGAOIONJV-KDWZCNHSSA-N
• SMILES: [2H]C1=C(C(=C(C(=C1C)[2H])[2H])S(=O)(=O)NC(=O)NN2CC3CCCC3C2)[2H]

Gliclazide-d4 (CAS 1185039-30-8) is a high-purity deuterated compound used in advanced pharmaceutical research. This isotopically labeled version of Gliclazide is essential for studies involving diabetes treatment, pharmacokinetics, and metabolic pathways. Featuring four deuterium atoms, it ensures precise and reliable analytical results. Its advanced formulation provides enhanced stability and consistency, making it suitable for various experimental setups. Ideal for endocrinology research and drug development, Gliclazide-d4 integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.